Disclosure: We earn commissions on purchases made through our links. This never influences our scores. Editorial policy
Rhodiola Rosea
Rhodiola is one of the few adaptogens with real clinical evidence behind it, especially for fatigue, cognitive performance under stress, and exercise endurance.
- Evidence
- Mixed Evidence
- Category
- Herbal & Botanical
- Best form
- Extract standardized to minimum 3% rosavins and 0.8-1% salidroside (3:1 ratio mirrors natural Rhodiola rosea rhizome composition)
- Effective dose
- 200-600mg daily of extract standardized to minimum 3% rosavins and 0.8-1% salidroside
- Lab tested
- 0 of 10 products
- Category
- Herbal & Botanical
- Best form
- Extract standardized to minimum 3% rosavins and 0.8-1% salidroside (3:1 ratio mirrors natural Rhodiola rosea rhizome composition)
- Effective dose
- 200-600mg daily of extract standardized to minimum 3% rosavins and 0.8-1% salidroside
- Lab tested
- 0 of 10 products
Key takeaways
- →One of the better-studied adaptogens: solid evidence for reducing fatigue, normalizing cortisol in burnout, and improving VO2max and time to exhaustion.
- →Use 200-600mg/day of extract standardized to 3% rosavins AND 0.8-1% salidroside, taken morning or early afternoon to avoid insomnia.
- →Nutricost 500mg ($0.27/day) is the value pick with proper standardization; NOW Foods 500mg ($0.32/day) is the close runner-up with NPA A-rated GMP.
- →Skip with bipolar disorder (manic episode risk), during pregnancy, or alongside SSRIs/MAOIs without medical supervision - theoretical serotonin syndrome risk.
What Is Rhodiola Rosea?
Rhodiola is one of the few adaptogens with real clinical evidence behind it, especially for fatigue, cognitive performance under stress, and exercise endurance. Only buy extracts standardized to at least 3% rosavins and 0.8-1.0% salidroside, the 3:1 ratio mirrors the natural rhizome composition and is the authenticity marker for genuine Rhodiola rosea. SHR-5 and WS 1375 are the specific extracts used in the strongest trials; unstandardized bulk powder is a gamble on whether the species is even correct. Effects typically appear within days to a few weeks at 170-600mg/day.
For acute fatigue reduction and cognitive performance, controlled trials consistently demonstrate significant benefits: in physicians on night duty, 170mg of SHR-5 extract improved Total Fatigue Index, associative thinking, short-term memory, and audio-visual perception; in military cadets, improved associative thinking, short-term memory, and calculation speed under stress conditions were observed within 2-3 weeks.
For chronic stress and burnout, controlled trials of 4+ weeks demonstrate robust, dose-dependent improvements in burnout scores, fatigue, motivation, cognitive function, and cortisol regulation. Effects appear as early as day 3 with WS 1375 extract (400mg/day) and show continuous improvement through 12 weeks. A 2017 multicenter burnout trial demonstrated no therapeutic plateau over 12 weeks.
Exercise performance evidence is moderate-to-strong: a 2025 meta-analysis of 26 RCTs (n=668, mean intervention duration 33 days) confirmed significant improvements in VO2max (ES=0.32, 95% CI [0.12, 0.52]), time to exhaustion (ES=0.38, 95% CI [0.07, 0.69]), time trial performance (ES=-0.40), antioxidant capacity (ES=0.59-1.16), and meaningful reductions in creatine kinase (ES=-0.84), lactate (ES=-0.87), and lipid peroxidation (ES=-1.21). Benefits are most pronounced at dosages exceeding 600mg daily, with trained athletes showing the greatest protective effects against muscle damage.
For mild-to-moderate depression, a rigorous 2015 RCT directly comparing Rhodiola rosea to sertraline found Rhodiola reduced HAM-D scores by -5.1 versus sertraline -8.2, but delivered a dramatically superior safety profile: 30% adverse event rate versus 63.2% for sertraline, with zero discontinuations in the Rhodiola arm. This favorable risk-to-benefit ratio makes Rhodiola a rational option for patients intolerant to conventional antidepressants.
Does It Work? The Evidence
How A-F grades workReduces physical and mental fatigue
Darbinyan et al. 2000 RCT (n=56, SHR-5 extract 170mg): significant improvements in Total Fatigue Index, associative thinking, short-term memory, and audio-visual perception in physicians undergoing night-duty sleep deprivation; Shevtsov et al. 2003 RCT (n=161): pronounced anti-fatigue effect in military cadets with significant improvements in associative thinking, short-term memory, and calculation speed
Improves cognitive performance under stress
Shevtsov et al. 2003 RCT (n=161): improved associative thinking, short-term memory, and calculation speed under stress conditions
Supports stress adaptation and burnout relief
Olsson et al. 2009 (n=60, SHR-5 extract 576mg/day x 28 days): highly significant decline in total burnout scores including emotional exhaustion and loss of power, with unique normalization of cortisol awakening response; Edwards et al. 2012 multicenter open-label trial (n=101, 13 UK sites, WS 1375 400mg/day divided into two 200mg doses x 4 weeks): significant improvements across 7 psychometric instruments (NAS, PSQ, MFI-20, NCT, SDS, MDMQ, CGI) including all MFI-20 fatigue subscales covering general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation, with effects observed as early as day 3 and continuous improvement at weeks 1 and 4; Kasper & Dienel 2017 multicenter trial (n=118 burnout outpatients): continuous improvement on Maslach Burnout Inventory and Perceived Stress Questionnaire over 12 weeks without plateau
Improves exercise endurance and reduces muscle damage
2025 meta-analysis of 26 RCTs (n=668, mean intervention 33 days): significant improvements in VO2max (ES=0.32, 95% CI [0.12, 0.52], 11 studies), time to exhaustion (ES=0.38, 95% CI [0.07, 0.69], 7 studies), time trial performance (ES=-0.40, 95% CI [-0.78, -0.01], 5 studies), total antioxidant capacity (ES=0.59), superoxide dismutase (ES=1.16), and reduced creatine kinase (ES=-0.84), lactate (ES=-0.87), and malondialdehyde (ES=-1.21); effects most pronounced at dosages exceeding 600mg/day; trained athletes showed greatest reductions in creatine kinase; De Bock et al. 2004 double-blind crossover RCT (n=24): acute 200mg increased time to exhaustion 16.8 to 17.2 min, VO2 peak 50.9 to 52.9 mL/min/kg, CO2 output 60.0 to 63.5 mL/min/kg; importantly, 4-week chronic loading at 200mg/day did NOT augment acute benefits - suggesting frontloading does not stack additively; Parisi et al. 2010 (n=14 highly trained male athletes, 4 weeks): recovery-focused benefits with significant reductions in post-exercise lactate, plasma CK (indicating myocyte membrane protection), and free fatty acids; time to exhaustion, VO2max, heart rate, and RPE were non-significant - chronic Rhodiola preserves tissue and accelerates recovery rather than improving raw performance metrics
Reduces symptoms of mild to moderate depression
Mao et al. 2015 RCT (PMID: 25837277, n=57 with DSM-IV Axis I MDD diagnosis, 12-week randomized double-blind placebo-controlled trial): Rhodiola rosea extract (3.07% rosavin, 1.95% salidroside, escalating 340-1360mg/day) vs sertraline (escalating 50-200mg/day) vs placebo - HAM-D score declined -5.1 (95% CI: -8.8 to -1.3) vs sertraline -8.2 (95% CI: -12.7 to -3.6) vs placebo -4.6; adverse events 30% Rhodiola vs 63.2% sertraline; zero discontinuations due to adverse events in Rhodiola arm vs multiple sertraline discontinuations from palpitations, severe headaches, insomnia, and sexual dysfunction; no clinically meaningful changes in blood pressure, pulse rate, body weight, or lab values; Darbinyan et al. 2007 (SHR-5, 340-680mg/day, 6 weeks): significant improvements in depressive scores, insomnia, and emotional instability
Reduces generalized anxiety symptoms
Bystritsky et al. 2008 open-label pilot (PMID: 18307390, n=10, 10 weeks, 340mg/day Rhodax extract): statistically significant improvement on Hamilton Anxiety Rating Scale, Four-Dimensional Anxiety and Depression Scale, and CGI Severity/Improvement Scale in patients with diagnosed GAD; proposed mechanism: activation of mu-opioid receptors in CNS and regulation of stress-induced adrenal catecholamine release; single small uncontrolled pilot - evidence base needs replication in RCTs
| Grade | Claimed Benefit | Key Studies | Our Verdict |
|---|---|---|---|
| A | Reduces physical and mental fatigue | Darbinyan et al. 2000 RCT (n=56, SHR-5 extract 170mg): significant improvements in Total Fatigue Index, associative thinking, short-term memory, and audio-visual perception in physicians undergoing night-duty sleep deprivation; Shevtsov et al. 2003 RCT (n=161): pronounced anti-fatigue effect in military cadets with significant improvements in associative thinking, short-term memory, and calculation speed | Supported |
| B | Improves cognitive performance under stress | Shevtsov et al. 2003 RCT (n=161): improved associative thinking, short-term memory, and calculation speed under stress conditions | Early Signal |
| B | Supports stress adaptation and burnout relief | Olsson et al. 2009 (n=60, SHR-5 extract 576mg/day x 28 days): highly significant decline in total burnout scores including emotional exhaustion and loss of power, with unique normalization of cortisol awakening response; Edwards et al. 2012 multicenter open-label trial (n=101, 13 UK sites, WS 1375 400mg/day divided into two 200mg doses x 4 weeks): significant improvements across 7 psychometric instruments (NAS, PSQ, MFI-20, NCT, SDS, MDMQ, CGI) including all MFI-20 fatigue subscales covering general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation, with effects observed as early as day 3 and continuous improvement at weeks 1 and 4; Kasper & Dienel 2017 multicenter trial (n=118 burnout outpatients): continuous improvement on Maslach Burnout Inventory and Perceived Stress Questionnaire over 12 weeks without plateau | Early Signal |
| B | Improves exercise endurance and reduces muscle damage | 2025 meta-analysis of 26 RCTs (n=668, mean intervention 33 days): significant improvements in VO2max (ES=0.32, 95% CI [0.12, 0.52], 11 studies), time to exhaustion (ES=0.38, 95% CI [0.07, 0.69], 7 studies), time trial performance (ES=-0.40, 95% CI [-0.78, -0.01], 5 studies), total antioxidant capacity (ES=0.59), superoxide dismutase (ES=1.16), and reduced creatine kinase (ES=-0.84), lactate (ES=-0.87), and malondialdehyde (ES=-1.21); effects most pronounced at dosages exceeding 600mg/day; trained athletes showed greatest reductions in creatine kinase; De Bock et al. 2004 double-blind crossover RCT (n=24): acute 200mg increased time to exhaustion 16.8 to 17.2 min, VO2 peak 50.9 to 52.9 mL/min/kg, CO2 output 60.0 to 63.5 mL/min/kg; importantly, 4-week chronic loading at 200mg/day did NOT augment acute benefits - suggesting frontloading does not stack additively; Parisi et al. 2010 (n=14 highly trained male athletes, 4 weeks): recovery-focused benefits with significant reductions in post-exercise lactate, plasma CK (indicating myocyte membrane protection), and free fatty acids; time to exhaustion, VO2max, heart rate, and RPE were non-significant - chronic Rhodiola preserves tissue and accelerates recovery rather than improving raw performance metrics | Supported |
| B | Reduces symptoms of mild to moderate depression | Mao et al. 2015 RCT (PMID: 25837277, n=57 with DSM-IV Axis I MDD diagnosis, 12-week randomized double-blind placebo-controlled trial): Rhodiola rosea extract (3.07% rosavin, 1.95% salidroside, escalating 340-1360mg/day) vs sertraline (escalating 50-200mg/day) vs placebo - HAM-D score declined -5.1 (95% CI: -8.8 to -1.3) vs sertraline -8.2 (95% CI: -12.7 to -3.6) vs placebo -4.6; adverse events 30% Rhodiola vs 63.2% sertraline; zero discontinuations due to adverse events in Rhodiola arm vs multiple sertraline discontinuations from palpitations, severe headaches, insomnia, and sexual dysfunction; no clinically meaningful changes in blood pressure, pulse rate, body weight, or lab values; Darbinyan et al. 2007 (SHR-5, 340-680mg/day, 6 weeks): significant improvements in depressive scores, insomnia, and emotional instability | Early Signal |
| D | Reduces generalized anxiety symptoms | Bystritsky et al. 2008 open-label pilot (PMID: 18307390, n=10, 10 weeks, 340mg/day Rhodax extract): statistically significant improvement on Hamilton Anxiety Rating Scale, Four-Dimensional Anxiety and Depression Scale, and CGI Severity/Improvement Scale in patients with diagnosed GAD; proposed mechanism: activation of mu-opioid receptors in CNS and regulation of stress-induced adrenal catecholamine release; single small uncontrolled pilot - evidence base needs replication in RCTs | Early Signal |
How to Choose: Forms, Doses & What Matters
Clinical dose: 200-600mg daily of extract standardized to minimum 3% rosavins and 0.8-1% salidroside
Best forms: Extract standardized to minimum 3% rosavins and 0.8-1% salidroside (3:1 ratio mirrors natural Rhodiola rosea rhizome composition), SHR-5 extract (used in multiple clinical trials)
Take in the morning or early afternoon - late dosing may cause insomnia due to its stimulating effects. Take on an empty stomach for best absorption. For larger doses (e.g., 400mg WS 1375), split into two doses taken before breakfast and before lunch, mirroring the Edwards et al. 2012 trial protocol. Consider cycling (e.g., 3 weeks on, 1 week off) to maintain effectiveness, though formal cycling protocols remain limited in the literature. Clinical trials predominantly used 200-600mg daily of standardized extract (minimum 3% rosavins, 0.8-1.0% salidroside); for exercise performance benefits, dosages exceeding 600mg daily showed the most significant VO2max and fatigue resistance improvements per the 2025 meta-analysis. Effects on acute mental fatigue and cognitive performance can be noticed within hours of a single dose. For chronic stress and burnout, clinical trials show measurable improvements beginning as early as day 3, with continuous gains over 4-12 weeks - no therapeutic plateau was observed even at 12 weeks in structured burnout trials.
Who Should Take Rhodiola Rosea?
Adults experiencing chronic stress or burnout who want an evidence-backed adaptogen. Shift workers or those with irregular sleep schedules looking to maintain cognitive performance. Athletes seeking physical and mental stamina during demanding training periods.
Who Should Avoid It?
Not for everyone
Side Effects & Safety
Product Scores
10 products scored on dosing accuracy, third-party testing, cost per effective dose, and label transparency.
The Scorecard: 10 Products Compared
Rhodiola Rosea 500mg, 60 Capsules
Nutricost$15.95 ÷ 59 days at 500mg/day (1 serving × 500mg)
Excellent price per properly standardized dose from a budget-focused brand
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola 500 mg
NOW Foods$19.10 ÷ 60 days at 500mg/day (1 serving × 500mg)
Excellent price for a properly standardized extract from a reputable brand with NPA A-rated GMP certification
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola Rosea Extract 500 mg
Double Wood Supplements$17.95 ÷ 120 days at 500mg/day (1 serving × 500mg)
Great bulk value but standardized to salidrosides only, lacking the 3% rosavin marker seen in most clinical trials
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola Rosea Extract 60 Capsules
Swanson
$12.69 ÷ 30 days at 700mg/day (2 servings × 350mg)
Transparent label but inclusion of 100mg unstandardized root powder takes up capsule space that could be used for more standardized extract
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola Extract, 250 mg
Life Extension$13.83 ÷ 30 days at 500mg/day (2 servings × 250mg)
Good mid-range option from a reputable brand, requires 2 capsules for a standard clinical dose
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola Rosea Extract Capsules | 500mg | 3% Rosavins
Nootropics Depot$27.99 ÷ 60 days at 500mg/day (1 serving × 500mg)
Highly respected brand for botanical standardizations with excellent transparency on active compound ratios
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola Rosea, 120 Liquid Phyto-Caps
Gaia Herbs$49.49 ÷ 60 days at 240mg/day (2 servings × 120mg)
Liquid phyto-caps may offer better absorption, but high price and missing salidroside disclosure are drawbacks
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola
Thorne$24.00 ÷ 15 days at 400mg/day (4 servings × 100mg)
Premium practitioner-grade brand but extremely expensive per clinical dose due to low 100mg per capsule
Prices checked 2026-03-31. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola Rosea Root Extract 2000mg | 180 Capsules
Horbaach$15.28 ÷ Infinity days at 0mg/day (0 servings × 2000mg)
Uses misleading 'equivalent' fresh root dosing - impossible to know the actual clinical dose being delivered without standardization
Prices checked 2026-04-25. Cost shown is per clinically effective daily dose, not per pill.
Rhodiola Rosea Extract | 1000mg | 120 Capsules
Piping Rock
$12.49 ÷ Infinity days at 0mg/day (0 servings × 1000mg)
Standardization is absent and dosing is deceptive - actual extract weight is roughly 200mg of unstandardized material
Prices checked 2026-04-25. Cost shown is per clinically effective daily dose, not per pill.
Full Comparison
| Category | Rhodiola Rosea 500mg, 60 Capsules Nutricost | Rhodiola 500 mg NOW Foods | Rhodiola Rosea Extract 500 mg Double Wood Supplements | Rhodiola Rosea Extract 60 Capsules Swanson | Rhodiola Extract, 250 mg Life Extension | Rhodiola Rosea Extract Capsules | 500mg | 3% Rosavins Nootropics Depot | Rhodiola Rosea, 120 Liquid Phyto-Caps Gaia Herbs | Rhodiola Thorne | Rhodiola Rosea Root Extract 2000mg | 180 Capsules Horbaach | Rhodiola Rosea Extract | 1000mg | 120 Capsules Piping Rock |
|---|---|---|---|---|---|---|---|---|---|---|
| Brand Score | 84/100Winner | 84/100 | 80/100 | 80/100 | 80/100 | 80/100 | 63/100 | 61/100 | 41/100 | 41/100 |
| Dosing & Form | 25/25Winner | 25/25 | 25/25 | 25/25 | 25/25 | 25/25 | 18/25 | 18/25 | 25/25 | 25/25 |
| Purity | 13/25Winner | 13/25 | 13/25 | 13/25 | 13/25 | 13/25 | 13/25 | 13/25 | 7/25 | 7/25 |
| Value | 23/25Winner | 23/25 | 23/25 | 19/25 | 19/25 | 19/25 | 13/25 | 7/25 | 2/25 | 2/25 |
| Transparency | 23/25Winner | 23/25 | 19/25 | 23/25 | 23/25 | 23/25 | 19/25 | 23/25 | 7/25 | 7/25 |
| Cost/Day | $0.27 | $0.32 | $0.15 | $0.42 | $0.46 | $0.47 | $0.82 | $1.60 | $0.00Winner | $0.00 |
| Dose/Serving | 500mg | 500mg | 500mg | 350mg | 250mg | 500mg | 120mg | 100mg | 2000mg | 1000mg |
| Form | Root Extract (standardized to 3% total rosavins and 1% salidrosides) | Root Extract (standardized to 3% total rosavins and 1% salidroside) | Root Extract (standardized to 3% salidrosides) | 250 mg Root Extract (standardized to 3% rosavins, 1% salidrosides) + 100 mg unstandardized root | Root Extract (standardized to 3% rosavins, NLT 1% salidrosides) | Root Extract (standardized to 3% rosavins, 1% salidrosides) | Organic Siberian Rhodiola Root Extract (standardized to 5% rosavins) | Root Extract (standardized to 3% rosavins) | Unstandardized root extract (Equivalent dose from proprietary ratio) | Unstandardized extract (from 5:1 ratio, equivalent to 1000mg root) |
| Third-Party Tested | No | No | No | No | No | No | No | No | No | No |
| Proprietary Blend | No | No | No | No | No | No | No | No | Yes | Yes |
Frequently Asked Questions
What should I look for on a rhodiola label?
Look for an extract standardized to 3% rosavins and 1% salidroside. This ratio mirrors the naturally occurring ratio in Rhodiola rosea root and matches the composition used in most clinical trials (SHR-5 extract). Products standardized only to salidrosides, or those using unstandardized 'equivalent' dosing, have less clinical backing.
How quickly does rhodiola work?
For acute fatigue and mental performance, rhodiola can work within hours of a single dose - several clinical trials showed cognitive benefits after just one dose. For chronic stress and burnout symptoms, expect 2-4 weeks of consistent daily use before noticing meaningful improvements.
Can I take rhodiola with caffeine?
Yes, rhodiola and caffeine are generally considered safe to combine. Some users find them complementary - rhodiola for sustained mental clarity and caffeine for alertness. However, both can be stimulating, so start with lower doses of each and avoid taking either late in the day if you are sensitive to sleep disruption.
Should I cycle rhodiola?
Many practitioners recommend cycling rhodiola (e.g., 3 weeks on, 1 week off) to maintain its adaptogenic effectiveness. While there is limited clinical data specifically on cycling protocols, anecdotal evidence suggests that continuous long-term use may lead to reduced benefits over time.
Why are some rhodiola products so much cheaper than others?
The main cost driver is standardization quality. Products with verified 3% rosavin and 1% salidroside content use higher-quality extracts. Budget products often use unstandardized root powder or 'equivalent' dosing that hides the actual extract weight, making it impossible to know if you are getting a clinically relevant dose.
Is rhodiola the same as ashwagandha?
No. Both are classified as adaptogens, but they have different active compounds and somewhat different benefit profiles. Rhodiola is more stimulating and better studied for acute fatigue and cognitive performance under stress. Ashwagandha is more calming and has stronger evidence for anxiety, cortisol reduction, and sleep quality. Some people use both, taking rhodiola in the morning and ashwagandha in the evening.
Related Articles
Sources
- Darbinyan V, et al. Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen. Phytomedicine. 2000;7(5):365-71.
- Olsson EM, et al. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75(2):105-12.
- Shevtsov VA, et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine. 2003;10(2-3):95-105.
- Spasov AA, et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period. Phytomedicine. 2000;7(2):85-89.
- De Bock K, et al. Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004;14(3):298-307.
- Mao JJ, et al. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine. 2015;22(3):394-9.
- Edwards D, et al. Therapeutic effects and safety of Rhodiola rosea extract WS 1375 in subjects with life-stress symptoms - results of an open-label study. Phytother Res. 2012;26(8):1220-5.
- Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481-93.
- Bystritsky A, et al. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder. J Altern Complement Med. 2008;14(2):175-80.
- Darbinyan V, et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry. 2007;61(5):343-8.
- Kasper S, Dienel A. Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms. Neuropsychiatr Dis Treat. 2017;13:889-898.
- Zhao Y, et al. The effect of Rhodiola rosea supplementation on endurance performance and related biomarkers: a systematic review and meta-analysis. Front Nutr. 2025.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products discussed on this page are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any supplement regimen.